88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual...
Garden City, New York--(Newsfile Corp. - October 18, 2024) - Silberstein, Awad & Miklos, P.C. (ASK4SAM), a leading personal injury...
SAN DIEGO, Oct. 18, 2024 /PRNewswire/ -- Cooler Heads, a leader in scalp cooling technology, celebrates a groundbreaking update in...
The “Powering Milwaukee Forward” initiative will fund 10 Milwaukee organizations to increase access to basic needs and maternal healthcare in...
LORTON, Va., Oct. 18, 2024 /PRNewswire/ -- Olight, a brand committed to becoming a global leader in mid-to-high-end flashlights, introduced...
Event to Raise Funds for Women in the Underserved Community in Los Angeles Struggling to Afford Cancer Treatment LOS ANGELES,...
HOUSTON, Oct. 18, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading...
Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet...
RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is contributing to...
If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence,...
Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an...
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Clinical Complete Responses Observed in 4 out of 5 Patients in Subset of Patients with Low Grade Disease; Evidence of...
To aid in the early detection of breast cancer, Enable Me is offering Tampa Bay area mammography clinics free use...
Fully Leased Life Science Campus is Now Home to Leading Companies Including Pfizer and BD Biosciences SAN DIEGO, Oct. 17,...
DALLAS, Oct. 17, 2024 /PRNewswire/ -- Crosetto Foundation for the Reduction of Cancer Deaths welcomes Transparency in Science. Italian-American scientist...
Evvy Names Dr. Kate McLean, MD, MPH, FACOG as Chief Medical Officer, publishes peer-reviewed validation paper for its at-home vaginal...
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK...
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK...
PRINCETON, NJ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage...